CON vs ASTH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 29, 2026

CON

52.7
AI Score
VS
ASTH Wins

ASTH

58.7
AI Score

Investment Advisor Scores

CON

53score
Recommendation
HOLD

ASTH

59score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CON ASTH Winner
Revenue 569.55M 965.10M ASTH
Net Income 50.49M 14.44M CON
Net Margin 8.9% 1.5% CON
Operating Income 95.61M 28.53M CON
ROE 11.9% 1.8% CON
ROA 1.7% 0.6% CON
Total Assets 2.89B 2.36B CON
Cash 61.70M 478.38M ASTH
Current Ratio 1.26 1.35 ASTH
Free Cash Flow 9.93M 64.06M ASTH

Relative Price Performance (Last 90 Days)

CON 1M: +2.9% · 3M: +40.9% ASTH 1M: -28.6% · 3M: +4.2%

Current Technical Phase

CON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.9% over 20 days), RSI 59

RSI (14): 58.9 · Price: $31.65

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 28

RSI (14): 28.1 · Price: $35.56

Fundamentals Snapshot

Metric CON ASTH
Market Cap
Forward P/E 18.7 10.4
Trailing P/E 22.7 60.1
Revenue (TTM)
Revenue Growth 0.1% 0.6%
Gross Margin 0.3% 0.1%
Operating Margin 0.2% 0.0%
EPS 1.39 0.61
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.